Medical Research
(H30)
IRS Verified
DX Registered
990 on File
HIPPOCRATIC CANCER RESEARCH FOUNDATION INC
Financial strength (30%)
91/100
Reliability (20%)
50/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
The mission of the Hippocratic Cancer Research Foundation is to discover, develop and implement effective new treatments for patients with cancer by advancing groundbreaking research.
Financial Overview — FY 2024
$939K
Total Revenue
$625K
Total Expenses
$567K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
80.0%
Fundraising Efficiency
N/A
Operating Reserve
10.88x
Liability-to-Asset
0.0%
Revenue Diversification
188.3%
Compared with Peers
FY 2024
Compared with 727 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
80.0% | 84.5% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
20.0% | 11.4% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
10.9 mo | 13.5 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.4% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
188.3% | 93.3% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
849.4% | 9.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-19.4% | 8.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
33.4% | 1.9% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $939K | $625K | $567K | 80.0% | 0 |
| 2023 | $99K | $776K | $233K | 90.3% | 0 |
| 2022 | $790K | $429K | $909K | 69.9% | 0 |
| 2021 | $544K | $606K | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.